U.S. government got $400 million in vaccine royalties from Moderna, company says
Pharmaceutical company Moderna indicated this week that it had sent the U.S. government a “catch-up” payment of $400 million in connection with a patent dispute.
Moderna enters R&D collaboration for mRNA gene-editing therapies
Moderna Inc will collaborate with privately-owned Life Edit Therapeutics Inc under an agreement to discover and develop mRNA gene-editing therapies, the companies said on Wednesday.
Featured
